Topic - Michael Kleinrock

Subscribe to this topic via RSS or ATOM
Related Stories
  • Slow growth expected in costs for medicines

    Spending on medicine will grow at historically low levels in the U.S. during the next two years while developing countries will see such spending double and match the U.S. market by 2016, a report released Thursday shows.

  • US prescription spending again nearly flat

    Spending on prescription drugs in the U.S. was nearly flat in 2011 at $320 billion, held down by senior citizens and others reducing use of medicines and other health care and by greater use of cheaper generic pills.

More Stories →

  • Mr. Kleinrock said drug sales will increase dramatically in 2014 when President Obama's health care law takes full effect, as an estimated 30 million uninsured Americans will have greater access to the products.

    Slow growth expected in costs for medicines →

  • "While the growth rate is really low, it's recovering through the period," Mr. Kleinrock said. "The U.S. is still the largest market. It's still where companies get most of their money."

    Slow growth expected in costs for medicines →

Happening Now